FARICIMAB\FARICIMAB-SVOA for Polypoidal choroidal vasculopathy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 43 adverse event reports in the FDA FAERS database where FARICIMAB\FARICIMAB-SVOA was used for Polypoidal choroidal vasculopathy.
Most Reported Side Effects for FARICIMAB\FARICIMAB-SVOA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| No adverse event | 1,553 | 46.9% | 0 | 0 |
| Off label use | 1,550 | 46.8% | 5 | 7 |
| Visual impairment | 208 | 6.3% | 1 | 10 |
| Drug ineffective | 176 | 5.3% | 0 | 2 |
| Uveitis | 153 | 4.6% | 0 | 6 |
| Eye inflammation | 124 | 3.7% | 0 | 4 |
| Vitreous floaters | 123 | 3.7% | 0 | 4 |
| Vision blurred | 99 | 3.0% | 0 | 1 |
| Vitritis | 99 | 3.0% | 0 | 8 |
| Endophthalmitis | 93 | 2.8% | 0 | 11 |
| Iridocyclitis | 91 | 2.8% | 0 | 6 |
| Death | 85 | 2.6% | 83 | 0 |
| Intraocular pressure increased | 70 | 2.1% | 0 | 0 |
| Visual acuity reduced | 70 | 2.1% | 0 | 2 |
| Eye pain | 69 | 2.1% | 1 | 1 |
Other Indications for FARICIMAB\FARICIMAB-SVOA
Neovascular age-related macular degeneration (1,019)
Product used for unknown indication (683)
Diabetic retinal oedema (434)
Choroidal neovascularisation (306)
Macular oedema (249)
Diabetic retinopathy (233)
Retinal vein occlusion (189)
Age-related macular degeneration (185)
Retinal neovascularisation (149)
Macular degeneration (111)
Other Drugs Used for Polypoidal choroidal vasculopathy
RANIBIZUMAB (315)
VERTEPORFIN (210)
AFLIBERCEPT (193)
BROLUCIZUMAB (70)
BROLUCIZUMAB-DBLL (64)
BEVACIZUMAB (46)
FLUOROURACIL (17)
IRINOTECAN (17)
LEUCOVORIN (17)
LUCENTIS (7)